Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AXGN | US
0.58
1.83%
Healthcare
Medical Devices
30/06/2024
13/03/2026
32.34
31.76
33.88
31.62
AxoGen Inc. together with its subsidiaries develops and markets technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap a porcine submucosa ECM product that is used to protect a peripheral nerve end as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals surgery centers and military hospitals plastic reconstructive surgeons orthopedic and plastic hand surgeons and various oral and maxillofacial surgeons. AxoGen Inc. is headquartered in Alachua Florida.
View LessStrength based on increasing price with high volume
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
47.7%1 month
51.3%3 months
46.3%6 months
57.6%-
36.76
6.06
0.72
0.37
-15.30
3.62
-
-6.05M
1.42B
1.42B
-
-0.89
-
25.60
-17.15
2.78
3.29
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
6.34
Range1M
8.35
Range3M
8.46
Rel. volume
1.10
Price X volume
33.99M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ARTIVION INC | AORT | Medical Devices | 36.39 | 1.52B | 0.61% | n/a | 122.90% |
| AtriCure Inc | ATRC | Medical Instruments & Supplies | 29.845 | 1.45B | 1.05% | n/a | 16.30% |
| AdaptHealth Corp | AHCO | Medical Devices | 10.595 | 1.42B | 8.67% | n/a | 150.02% |
| Tandem Diabetes Care Inc | TNDM | Medical Devices | 21.59 | 1.41B | 3.43% | n/a | 204.00% |
| PROCEPT BioRobotics Corporation Common Stock | PRCT | Medical Devices | 27.13 | 1.41B | 3.87% | n/a | 32.18% |
| Pulse Biosciences Inc | PLSE | Medical Instruments & Supplies | 21.57 | 1.32B | 1.27% | n/a | 32.05% |
| Move Inc | MOVE | Medical Devices | 13.24 | 1.31B | 1.61% | n/a | 0.85% |
| IRadimed Corporation | IRMD | Medical Devices | 99.69 | 1.26B | 0.32% | 35.49 | 0.47% |
| CONMED Corporation | CNMD | Medical Devices | 37.28 | 1.15B | 1.50% | 21.14 | 109.53% |
| AZTA | AZTA | Medical Instruments & Supplies | 21.42 | 1.05B | 0.23% | n/a | 3.59% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Kennedy-Wilson Holdings Inc | KW | Real Estate Services | 10.87 | 1.49B | 0.00% | n/a | 304.03% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 13.6 | 1.36B | 0.67% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 37.61 | 1.18B | 0.89% | 51.60 | 88.92% |
| Marcus & Millichap Inc | MMI | Real Estate Services | 25.42 | 984.50M | -1.70% | n/a | 14.11% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.17 | 751.31M | -1.15% | 11.62 | 116.21% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.02 | 695.77M | -1.79% | 65.18 | 77.00% |
| Comstock Mining Inc | LODE | Real Estate Services | 3.15 | 650.90M | -5.12% | 6.38 | 14.37% |
| Ennis Inc | EBF | Building Products & Equipment | 21.15 | 549.98M | -0.52% | 13.28 | 2.28% |
| The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 2.35 | 464.72M | -4.86% | n/a | 0.00% |
| FRP Holdings Inc | FRPH | Real Estate Services | 22.57 | 429.52M | 0.22% | 75.50 | 42.65% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -15.30 | - | Cheaper |
| Ent. to Revenue | 3.62 | - | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 6.06 | 6.21 | Par |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 46.27 | - | Lower Risk |
| Debt to Equity | 0.72 | -145.53 | Expensive |
| Debt to Assets | 0.37 | 0.35 | Par |
| Market Cap | 1.42B | - | Emerging |